Home › Funds › Bain Capital Life Sciences Investors, LLC › TARS

Bain Capital Life Sciences Investors, LLC position in TARS

TARSUS PHARMACEUTICALS INC · Health Care

Bain Capital Life Sciences Investors, LLC reported holding 1,096,141 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$86.2M, representing 5.93% of its reported portfolio and ranking #7 among its reported holdings. Bain Capital Life Sciences Investors, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)1.10M sh
Reported value held$86.17M
Portfolio Weight5.93%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's TARS position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in TARS in Q3 2026 at 1,096,141 shares (US$86.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 1.10M $86.17M New

About TARS and 13F data

TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$299.3M), RTW INVESTMENTS, LP (US$273.9M), Paradigm Biocapital Advisors LP (US$180.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARS

All TARS fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held TARS?

Bain Capital Life Sciences Investors, LLC has disclosed TARS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Bain Capital Life Sciences Investors, LLC's current position in TARS?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 1.10M shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $86.17M, representing 5.93% of its reported portfolio and ranking #7.

Has Bain Capital Life Sciences Investors, LLC been buying or selling TARS?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC newly opened its position in TARS.

Which other funds hold TARS?

Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.